Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Pump's daily trading recs, emphasis on short selling -- Ignore unavailable to you. Want to Upgrade?

To: Michail Shadkin who wrote (2114)	6/13/2001 10:16:02 AM
From: gaj	Read Replies (1) \| Respond to of 6873

nvgn - shorted some at etrade on the huge spike, then went to short some more and they were out... watley has noshares, either.

To: Michail Shadkin who wrote (2114)	6/13/2001 11:07:31 AM
From: allen menglin chen	Read Replies (1) \| Respond to of 6873

NVGN $1.1/share issued just on June 1! STAMFORD, Conn.--(BW HealthWire)--June 1, 2001--Novogen Limited (Nasdaq:NVGN - news) raised US$11.2 million from international institutional investors through the issue of 10.55 million ordinary shares in the Company, according to company officials. biz.yahoo.com Another Aussie scam? :) The Cleveland Clinic Foundation and Novogen Announce the Start of the First Phase Ib U.S. Trial for Investigational Anti-Cancer Drug Phenoxodiol biz.yahoo.com It's many yrs away from Phase 3, the last phase b4 a successful drug.